Oklo is trading 10.68% up now at $43.93, primarily amid a broad nuclear-sector rebound.
- No newly announced company-specific catalyst was identified for August 25, 2026.
- Renewed coverage highlighted Oklo’s Groves Isotope Test Reactor reaching first criticality on August 5 and its DOE Reactor Pilot Program significance; project supplier Facility Solutions Group publicized the earlier milestone.
- Broader markets are modestly higher, but the approximately 5% nuclear-sector rebound appears the stronger identifiable influence.